Literature DB >> 17509631

The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values.

Shimin Zhang1, Jacqueline Jonklaas, Mark Danielsen.   

Abstract

Mifepristone is an antagonist of the glucocorticoid receptor (GR) that also has significant agonist activity in some cell types. We examined the partial agonist activity of mifepristone in COS-7 cells transfected with increasing amounts of a glucocorticoid receptor expression vector pmGR. As pmGR levels increased, the response of the reporter, pMTVCAT to dexamethasone increased, consistent with increasing levels of receptor expression; the response to mifepristone also increased but at a higher rate, resulting in increasing mifepristone agonist and decreasing antagonist activity. In contrast, increasing pMTVCAT levels increased CAT activity induced by both dexamethasone and mifepristone, but did not change the relative agonist activity of mifepristone. We also examined the relationship between agonist activity and receptor level in a series of clones of the E8.2.A3 cell line expressing various levels of GR. Again, the relative agonist activity of mifepristone increased as GR increased. This increase was not due to changes in the dose response curves to these two ligands since their EC50 values were independent of receptor levels. These results indicate that the degree of glucocorticoid agonist activity exhibited by mifepristone is dependent on the concentration of GR in the cell. Similar results were obtained with another partial agonist of the GR, progesterone, whereas the complete antagonist ZK98.299 had no agonist activity under any condition. Taken together, these results suggest that the phenomenon of receptor concentration-dependence is a property of partial GR agonists in general.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509631     DOI: 10.1016/j.steroids.2007.03.012

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  33 in total

1.  An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics.

Authors:  T Joshi; M Johnson; R Newton; M Giembycz
Journal:  Br J Pharmacol       Date:  2015-01-08       Impact factor: 8.739

2.  Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint I. Role of progesterone receptors.

Authors:  James Hassell; Chandra Suma Johnson Miryala; Cindy Hiegel; Lynda Uphouse
Journal:  Horm Behav       Date:  2011-05-20       Impact factor: 3.587

Review 3.  A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids.

Authors:  M A Giembycz; M Kaur; R Leigh; R Newton
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

Review 4.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

5.  Glucocorticoid treatment of astrocytes results in temporally dynamic transcriptome regulation and astrocyte-enriched mRNA changes in vitro.

Authors:  Bradley S Carter; Fan Meng; Robert C Thompson
Journal:  Physiol Genomics       Date:  2012-10-30       Impact factor: 3.107

Review 6.  The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors.

Authors:  George Briassoulis; Svetozar Damjanovic; Paraskevi Xekouki; Hervé Lefebvre; Constantine A Stratakis
Journal:  Endocr Pract       Date:  2011 Nov-Dec       Impact factor: 3.443

7.  Sex differences in cell proliferation and glucocorticoid responsiveness in the zebra finch brain.

Authors:  Amnon Katz; Anahid Mirzatoni; Yin Zhen; Barney A Schlinger
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

8.  An antiprogestin, CDB4124, blocks progesterone's attenuation of the negative effects of a mild stress on sexual behavior.

Authors:  Lynda Uphouse; Cindy Hiegel
Journal:  Behav Brain Res       Date:  2012-11-12       Impact factor: 3.332

9.  A miniaturized glucocorticoid receptor translocation assay using enzymatic fragment complementation evaluated with qHTS.

Authors:  Ping Jun Zhu; Wei Zheng; Douglas S Auld; Ajit Jadhav; Ryan Macarthur; Keith R Olson; Kun Peng; Hyna Dotimas; Christopher P Austin; James Inglese
Journal:  Comb Chem High Throughput Screen       Date:  2008-08       Impact factor: 1.339

10.  RU486 blocks effects of allopregnanolone on the response to restraint stress.

Authors:  Lynda Uphouse; Sarah Adams; Chandra Suma Johnson Miryala; James Hassell; Cindy Hiegel
Journal:  Pharmacol Biochem Behav       Date:  2012-10-06       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.